Clinical trialNCT00984867CompletedPhase 3Interventional

Dapagliflozin DPPIV Inhibitor add-on Study

SponsorAstraZenecaEnrollment833Type 2 Diabetes

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Serge Jabbour, MD
Thomas Jefferson University, Philadelphia
Principal InvestigatorKOL profile →
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

88 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Argentina

Research Site
Berazategui, Buenos Aires, Argentina
Research Site
La Plata, Buenos Aires, Argentina
Research Site
Lanus, Buenos Aires, Argentina
Research Site
Mar del Plata, Buenos Aires, Argentina
Research Site
Morón, Buenos Aires, Argentina
Research Site
Buenos Aires, Buenos Aires F.D., Argentina
Research Site
Caba, Buenos Aires F.D., Argentina
Research Site
Córdoba, Córdoba Province, Argentina
Research Site
Salta, Salta Province, Argentina
Research Site
Santa Fe, Santa Fe Province, Argentina

Germany

Research Site
Bad Nauheim, Germany
Research Site
Berlin, Germany
Research Site
Dresden, Germany
Research Site
Hamburg, Germany
Research Site
Meissen, Germany
Research Site
Münster, Germany
Research Site
Pirna, Germany
Research Site
Wangen, Germany

Mexico

Research Site
Guadalajara, Jalisco, Mexico
Research Site
Mexico City, Mexico City, Mexico

Poland

Research Site
Ciechocinek, Poland
Research Site
Czechowice-Dziedzice, Poland
Research Site
Gdansk, Poland
Research Site
Gniewkowo, Poland
Research Site
Krakow, Poland
Research Site
Krotoszyn, Poland
Research Site
Mrągowo, Poland
Research Site
Poznan, Poland
Research Site
Sopot, Poland
Research Site
Torun, Poland
Research Site
Zabrze, Poland
Research Site
Łęczyca, Poland

United Kingdom

Research Site
Bolton, Lancs, United Kingdom
Research Site
Burbage, Leicester, United Kingdom
Research Site
Sunbury-on-Thames, Middlesex, United Kingdom
Research Site
Wansford, Peterborough, United Kingdom
Research Site
Ecclesfield, Sheffield, United Kingdom
Research Site
Addlestone, Surrey, United Kingdom
Research Site
Bath, United Kingdom
Research Site
Belfast, United Kingdom

48 more sites on the registry record.ClinicalTrials.gov ↗

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 31 Oct 2009
Primary completion: 31 Mar 2011
Completion: 30 Sept 2011
Last update posted: 13 Jun 2014
Registered enrollment: 833
Registry id: NCT00984867

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.